Competitive Technologies, Inc. Files FDA Application for Pain Management Device

FAIRFIELD, Conn., May 5, 2008 (PRIME NEWSWIRE) -- Competitive Technologies, Inc. (AMEX:CTT) announced today that it has applied for FDA 510(k) medical device authorization for U.S. sales of its pain management therapy device. The CTT device has Medical Device CE certification from the European Union allowing European sales for this non-invasive method for rapid treatment of high-intensity oncologic and neuropathic pain, including pain resistant to morphine and other drugs. CTT has exclusive worldwide rights to this patented device.